| NDC Code | 63323-122-50 |
|---|
| Package Description | 1 VIAL in 1 CARTON (63323-122-50) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
|---|
| Product NDC | 63323-122 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Methotrexate |
|---|
| Non-Proprietary Name | Methotrexate Sodium |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS |
|---|
| Start Marketing Date | 20000122 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA040266 |
|---|
| Manufacturer | Fresenius Kabi USA, LLC |
|---|
| Substance Name | METHOTREXATE SODIUM |
|---|
| Strength | 1 |
|---|
| Strength Unit | g/1 |
|---|
| Pharmacy Classes | Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA] |
|---|